P4 What Can the US Learn from Regulatory Decisions and Health Technology Assessments of New Drugs in Other Countries?
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.012
https://www.valueinhealthjournal.com/article/S1098-3015(22)00211-X/fulltext
Title :
P4 What Can the US Learn from Regulatory Decisions and Health Technology Assessments of New Drugs in Other Countries?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00211-X&doi=10.1016/j.jval.2022.04.012
First page :
Section Title :
Open access? :
No
Section Order :
10005